HUNT VALLEY, Md. & EAST WINDSOR, N.J.--(BUSINESS WIRE)--PII, (Pharmaceutics International, Inc.) and NexMed, Inc. (Nasdaq: NEXM) announced today that they have signed a Memorandum of Understanding (MOU) for a strategic product development collaboration utilizing NexMed’s NexACT drug delivery platform.
